Bicycle Therapeutics Ownership | Who Owns Bicycle Therapeutics?
Bicycle Therapeutics Ownership Summary
Bicycle Therapeutics is owned by 58.62% institutional investors, 1.30% insiders, and 40.08% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 22.09% of BCYC shares. T. Rowe Price Health Sciences is the top mutual fund, with 1.74% of its assets in Bicycle Therapeutics shares.
BCYC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Bicycle Therapeutics | 58.62% | 1.30% | 40.08% |
| Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
| Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Baker bros. advisors lp | 9.40M | 22.09% | $190.26M |
| Deep track capital, lp | 3.49M | 8.20% | $70.65M |
| Ra capital management | 2.25M | 5.29% | $45.60M |
| Fcpm iii services b.v. | 2.12M | 4.99% | $42.97M |
| Armistice capital | 1.97M | 4.63% | $39.91M |
| Westfield capital management co lp | 1.52M | 3.58% | $30.84M |
| Tybourne capital management (hk) | 1.51M | 3.55% | $30.56M |
| First light asset management | 1.38M | 3.25% | $28.03M |
| Morgan stanley | 1.23M | 2.89% | $24.93M |
| Fairmount funds management | 1.07M | 2.51% | $21.64M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Fcpm iii services b.v. | 2.12M | 6.34% | $42.97M |
| Tybourne capital management (hk) | 1.51M | 6.21% | $30.56M |
| Aquilo capital management | 156.69K | 3.06% | $3.17M |
| First light asset management | 1.38M | 2.46% | $28.03M |
| Fairmount funds management | 1.07M | 2.44% | $21.64M |
| Baker bros. advisors lp | 9.40M | 2.43% | $190.26M |
| Deep track capital, lp | 3.49M | 2.11% | $70.65M |
| Parkman healthcare partners | 535.06K | 1.45% | $10.83M |
| Highvista strategies | 127.25K | 0.94% | $2.58M |
| Alphacentric advisors | 60.00K | 0.89% | $1.21M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Baker bros. advisors lp | 9.40M | 2.43% | 4.46M |
| Fcpm iii services b.v. | 2.12M | 6.34% | 2.12M |
| Ra capital management | 2.25M | 0.60% | 1.45M |
| Fairmount funds management | 1.07M | 2.44% | 1.07M |
| Ecor1 capital | 910.00K | 0.56% | 910.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Paradigm biocapital advisors lp | - | - | -3.25M |
| Suvretta capital management | - | - | -914.48K |
| Avoro capital advisors | - | - | -700.00K |
| Woodline partners lp | - | - | -586.62K |
| Morgan stanley | 1.23M | 0.00% | -285.14K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Fcpm iii services b.v. | 2.12M | 6.34% | 2.12M | $42.97M |
| Fairmount funds management | 1.07M | 2.44% | 1.07M | $21.64M |
| Ecor1 capital | 910.00K | 0.56% | 910.00K | $18.42M |
| Perceptive advisors | 572.00K | 0.27% | 572.00K | $11.58M |
| Aquilo capital management | 156.69K | 3.06% | 156.69K | $3.17M |
Sold Out
| Holder | Change |
|---|---|
| Zurcher kantonalbank (zurich cantonalbank) | -4.00 |
| Mather group, llc. | -5.00 |
| Northwestern mutual wealth management | -5.00 |
| Gen-wealth partners | -39.00 |
| Group one trading | -91.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 110 | 1.85% | 40,440,427 | 1.84% | 58 | 1.00% | 55 | -9.84% | 32 | 28.00% |
| Jun 30, 2024 | 107 | 11.46% | 39,708,441 | 30.36% | 93 | 1.81% | 60 | 42.86% | 25 | -24.24% |
| Mar 31, 2024 | 96 | -10.28% | 30,461,275 | -2.88% | 71 | 1.14% | 42 | -25.00% | 33 | 3.13% |
| Dec 31, 2023 | 107 | 2.88% | 31,365,344 | -3.19% | 79 | 0.69% | 56 | -6.67% | 32 | 39.13% |
| Sep 30, 2023 | 104 | 18.18% | 32,400,076 | 33.05% | 107 | 1.63% | 60 | 53.85% | 23 | -17.86% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| T. Rowe Price Health Sciences | 1.20M | 1.74% | -113.57K |
| Harbor Small Cap Growth Instl | 986.50K | 1.43% | 118.00K |
| Westfield Capital Mgt Co Sm-Cap Gr Eq | 986.50K | 1.43% | 139.03K |
| BNP Paribas Health Cr Innovtr Cl Cap | 566.30K | 0.82% | 7.71K |
| Belfius Equities Cure C Cap | 556.31K | 0.81% | 58.09K |
| Candriam Eqs L Biotech C USD Cap | 531.53K | 0.77% | -26.93K |
| Candriam Global Equities Oncology | 492.11K | 0.71% | 125.18K |
| BNP Paribas US Small Cap Classic R | 366.13K | 0.53% | 81.13K |
| Polar Capital Biotech S Inc | 297.67K | 0.43% | -592.95K |
| AXA Framlington Health Fund - R Income | 273.98K | 0.40% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 06, 2025 | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Sell | $40.29K |
| Jan 03, 2025 | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Sell | $2.35K |
| Jan 02, 2025 | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Sell | $24.66K |
| Jan 02, 2025 | Young Alethia | Chief Financial Officer | Sell | $19.66K |
| Jan 02, 2025 | Arroyo Santiago | CHIEF DEVELOPMENT OFFICER | Sell | $69.65K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | 10 | 11 |
| 2024 Q3 | - | 7 |
| 2024 Q2 | - | 7 |
| 2024 Q1 | - | 6 |
| 2023 Q4 | - | 6 |
BCYC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools